IMARC Group’s report titled “United States In Vitro Diagnostics Market Report by Test Type (Clinical Chemistry, Molecular Diagnostics, Immunodiagnostics, Hematology, and Others), Product (Reagent and Kits, Instruments), Usability (Disposable IVD Devices, Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Others), End User (Hospitals Laboratories, Clinical Laboratories, Point-of-care Testing Centers, Academic Institutes, Patients, and Others), and Region 2024-2032” The United States in vitro diagnostics market size is projected to exhibit a growth rate (CAGR) of 4.6% during 2024-2032.
The growing occurrence of chronic and infectious diseases as well as the escalating need for early and precision diagnostic testing are the factors responsible for the growth of the United States in vitro diagnostics market. Additionally, the demand for in vitro diagnostics is rising as they are essential tools in disease detection, management, and prevention, which is fueling the market. Besides this, the aging population in the U.S. is a significant factor contributing to this growth, as older adults are more susceptible to chronic conditions such as diabetes, cardiovascular diseases, and cancer. Furthermore, the COVID-19 pandemic has underscored the critical role of diagnostics, leading to a surge in the need for rapid and reliable testing solutions and significantly expanding the market.
Grab a sample PDF of this report: https://www.imarcgroup.com/united-states-in-vitro-diagnostics-market/requestsample
United States In Vitro Diagnostics Market Trends and Drivers:
Technological advancements are playing a pivotal role in shaping the United States in vitro diagnostics market. In addition to this, innovations in molecular diagnostics, such as next-generation sequencing (NGS) and polymerase chain reaction (PCR), have enhanced the accuracy and speed of diagnostic tests, enabling more precise and personalized medical care, which is acting as another growth-inducing factor. The integration of artificial intelligence (AI) and machine learning in diagnostics is further revolutionizing the field by improving data analysis and predictive capabilities. Moreover, regulatory support and favorable reimbursement policies are also driving market growth, as they ensure that new diagnostic tests are both accessible and affordable. In line with this, the increasing focus on point-of-care testing, which allows for rapid results outside of traditional laboratory settings, is meeting the demand for convenient and timely diagnostics, which is anticipated to drive the United States in vitro diagnostics market over the forecasted period.
Report Segmentation:
The report has segmented the market into the following categories:
Test Type Insights:
- Clinical Chemistry
- Molecular Diagnostics
- Immunodiagnostics
- Hematology
- Others
Product Insights:
- Reagents and Kits
- Instruments
Usability Insights:
- Disposable IVD Devices
- Reusable IVD Devices
Application Insights:
- Infectious Disease
- Diabetes
- Cancer/Oncology
- Cardiology
- Autoimmune Disease
- Nephrology
- Others
End User Insights:
- Hospitals Laboratories
- Clinical Laboratories
- Point-of-care Testing Centers
- Academic Institutes
- Patients
- Others
Regional Insights:
- Northeast
- Midwest
- South
- West
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163